0001213900-21-031126.txt : 20210607
0001213900-21-031126.hdr.sgml : 20210607
20210607064329
ACCESSION NUMBER: 0001213900-21-031126
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210528
FILED AS OF DATE: 20210607
DATE AS OF CHANGE: 20210607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RASTER INVESTMENTS, Inc
CENTRAL INDEX KEY: 0001858697
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54933
FILM NUMBER: 21998168
BUSINESS ADDRESS:
STREET 1: 2384 ORCHARD CREST BLVD
CITY: MANASQUAN
STATE: NJ
ZIP: 08736
BUSINESS PHONE: 732-938-6600
MAIL ADDRESS:
STREET 1: 2384 ORCHARD CREST BLVD
CITY: MANASQUAN
STATE: NJ
ZIP: 08736
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immune Therapeutics, Inc.
CENTRAL INDEX KEY: 0001559356
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 593226705
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2431 ALOMA AVE #124
CITY: WINTER PARK
STATE: FL
ZIP: 32792
BUSINESS PHONE: (888) 613-8802
MAIL ADDRESS:
STREET 1: 2431 ALOMA AVE #124
CITY: WINTER PARK
STATE: FL
ZIP: 32792
FORMER COMPANY:
FORMER CONFORMED NAME: TNI BIOTECH, INC.
DATE OF NAME CHANGE: 20121001
3
1
ownership.xml
X0206
3
2021-05-28
0
0001559356
Immune Therapeutics, Inc.
IMUN
0001858697
RASTER INVESTMENTS, Inc
2384 ORCHARD CREST BLVD
MANASQUAN,
NJ
08736
0
0
0
1
Member of 10% owner group
Common Stock
5650
D
Warrants (Right to Buy)
5.00
2018-12-31
2023-12-30
Common Stock
12000
D
Warrants (Right to Buy)
5.00
2019-05-31
2024-05-29
Common Stock
8000
D
According to the Annual Report on Form 10-K filed on April 15, 2021 (the "Form 10-K") by the issuer, Immune Therapeutics, Inc. (the "Company"), a reverse stock split of the Company's issued and outstanding, but not authorized, common stock at a ratio of 1,000-to-1 (the "Reverse Split") was approved by the Company's shareholders. The Reverse Split is currently pending approval by the Financial Industry Regulatory Authority, Inc. The information contained in the Form 10-K relating to the shares of Common Stock outstanding and beneficially owned is based on the implementation of the Reverse Split. The information presented herein is likewise based on the implementation of the Reverse Split. The beneficial ownership information presented in this Form 3 is otherwise based on the beneficial ownership of the Reporting Persons as of the date of the event requiring filing of this Form 3.
/s/ Raster Investments, Inc.; By Marie Elena Teraskiewicz, Director
2021-05-28